Accessibility Tools
Clinically active IBD linked to adverse COVID-19 outcomes

Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 27 in the Journal of Crohn's and Colitis.

Source: Medical Xpress

Read more

  • American Society for Gastrointestinal Endoscopy
  • American College of Gastroenterology
  • American Gastroenterological Association
  • American Association for the Study of Liver Diseases